Leadxpro Ag Is A Biotechnology Company Based In Villigenswitzerlandfounded In 2015 As A Spin Out From The Paul Scherrer Institutethe Company Specializes In Structure Based Drug Discovery For Membrane Proteinsfocusing On Challenging Targets Such As Gpcrsion Channelstransportersand Membrane Bound Enzymesleadxpro Offers Comprehensive Solutions For Drug Discoveryincluding Target Structure Resolution Using Advanced Techniques Like Synchrotron And Cryo Electron Microscopyhit Identification Through Biophysical Screeningand Preclinical Optimization Of Lead Compoundsthe Company Collaborates With Academic Institutions And Industry Leaders To Tackle Complex Drug Discovery Challengesensuring That Clients Retain Exclusivity And Ip Rights For Their Targetswith A Team Of Approximately 28 To 32 Employeesleadxpro Aims To Unlock New Therapeutic Opportunities In Fields Such As Neurologyoncologyand Metabolic Diseases
